Accuracy of serum neurofilament light to identify contrast-enhancing lesions in multiple sclerosis
Abstract
Contrast-enhancing magnetic resonance imaging (MRI) lesions (CELs) indicate acute multiple sclerosis inflammation. Serum biomarkers, neurofilament light (sNfL), and glial fibrillary acidic protein (sGFAP) may increase in the presence of CELs, and indicate a need to perform MRI.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Sep 15, 2023
- Source ID
- 10.1177/13524585231198751
Entities
People
- Bonnie I Glanz
- Brian C. Healy
- Christian Barro
- Gauruv Bose
- Howard L. Weiner
- Hrishikesh A. Lokhande
- Mariann Polgar-Turcsanyi
- Rohit Bakshi
- Shrishti Saxena
- Tanuja Chitnis
- Vanessa F Moreira Ferreira
Organizations
- Brigham and Women's Hospital
- Harvard Medical School
- MS Walk
- United States Department of Defense
- University of Ottawa